UniProt ID | KCRU_HUMAN | |
---|---|---|
UniProt AC | P12532 | |
Protein Name | Creatine kinase U-type, mitochondrial | |
Gene Name | CKMT1A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 417 | |
Subcellular Localization |
Mitochondrion inner membrane Peripheral membrane protein Intermembrane side. |
|
Protein Description | Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate). Creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa.. | |
Protein Sequence | MAGPFSRLLSARPGLRLLALAGAGSLAAGFLLRPEPVRAASERRRLYPPSAEYPDLRKHNNCMASHLTPAVYARLCDKTTPTGWTLDQCIQTGVDNPGHPFIKTVGMVAGDEETYEVFADLFDPVIQERHNGYDPRTMKHTTDLDASKIRSGYFDERYVLSSRVRTGRSIRGLSLPPACTRAERREVERVVVDALSGLKGDLAGRYYRLSEMTEAEQQQLIDDHFLFDKPVSPLLTAAGMARDWPDARGIWHNNEKSFLIWVNEEDHTRVISMEKGGNMKRVFERFCRGLKEVERLIQERGWEFMWNERLGYILTCPSNLGTGLRAGVHIKLPLLSKDSRFPKILENLRLQKRGTGGVDTAATGGVFDISNLDRLGKSEVELVQLVIDGVNYLIDCERRLERGQDIRIPTPVIHTKH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 | Phosphorylation | GPFSRLLSARPGLRL CHHHHHHHCCCHHHH | 27.16 | 24719451 | |
40 | Ubiquitination | RPEPVRAASERRRLY CCHHCCCHHHHHCCC | 11.02 | 30230243 | |
47 | Phosphorylation | ASERRRLYPPSAEYP HHHHHCCCCCCCCCC | 15.99 | 30266825 | |
50 | Phosphorylation | RRRLYPPSAEYPDLR HHCCCCCCCCCCCHH | 29.27 | 30266825 | |
53 | Phosphorylation | LYPPSAEYPDLRKHN CCCCCCCCCCHHHCC | 11.19 | 30266825 | |
62 | S-nitrosylation | DLRKHNNCMASHLTP CHHHCCCCCHHHCCH | 2.67 | 24105792 | |
70 | Ubiquitination | MASHLTPAVYARLCD CHHHCCHHHHHHHCC | 11.17 | 23503661 | |
72 (in isoform 2) | Phosphorylation | - | 6.52 | 26552605 | |
75 (in isoform 2) | Phosphorylation | - | 3.18 | 26552605 | |
77 (in isoform 2) | Phosphorylation | - | 56.80 | 26552605 | |
78 | Acetylation | VYARLCDKTTPTGWT HHHHHCCCCCCCCCC | 53.99 | 26051181 | |
81 (in isoform 2) | Phosphorylation | - | 33.86 | 26552605 | |
82 | Phosphorylation | LCDKTTPTGWTLDQC HCCCCCCCCCCHHHH | 43.17 | 23909892 | |
84 (in isoform 2) | Phosphorylation | - | 9.03 | 26552605 | |
85 | Phosphorylation | KTTPTGWTLDQCIQT CCCCCCCCHHHHHHH | 23.08 | 23909892 | |
89 | Glutathionylation | TGWTLDQCIQTGVDN CCCCHHHHHHHCCCC | 2.19 | 22555962 | |
92 | Phosphorylation | TLDQCIQTGVDNPGH CHHHHHHHCCCCCCC | 21.18 | 23909892 | |
107 | Ubiquitination | PFIKTVGMVAGDEET CCEEEEEEECCCHHH | 1.30 | 24816145 | |
116 | Ubiquitination | AGDEETYEVFADLFD CCCHHHHHHHHHHHH | 38.28 | 24816145 | |
141 | Phosphorylation | DPRTMKHTTDLDASK CCCCCCCCCCCCHHH | 19.25 | 20833797 | |
147 | Phosphorylation | HTTDLDASKIRSGYF CCCCCCHHHCCCCCC | 28.43 | 26437602 | |
148 | Ubiquitination | TTDLDASKIRSGYFD CCCCCHHHCCCCCCC | 43.81 | 24816145 | |
151 | Phosphorylation | LDASKIRSGYFDERY CCHHHCCCCCCCCEE | 41.12 | 28152594 | |
153 | Phosphorylation | ASKIRSGYFDERYVL HHHCCCCCCCCEEEE | 14.76 | 21082442 | |
157 | Methylation | RSGYFDERYVLSSRV CCCCCCCEEEEECCC | 28.80 | - | |
158 | Phosphorylation | SGYFDERYVLSSRVR CCCCCCEEEEECCCC | 12.05 | 20068231 | |
161 | Phosphorylation | FDERYVLSSRVRTGR CCCEEEEECCCCCCC | 13.17 | 20068231 | |
162 | Phosphorylation | DERYVLSSRVRTGRS CCEEEEECCCCCCCC | 30.54 | 20068231 | |
166 | Phosphorylation | VLSSRVRTGRSIRGL EEECCCCCCCCCCCC | 33.81 | 21406692 | |
169 | Phosphorylation | SRVRTGRSIRGLSLP CCCCCCCCCCCCCCC | 20.27 | 20068231 | |
174 | Phosphorylation | GRSIRGLSLPPACTR CCCCCCCCCCCCCCH | 41.47 | 20068231 | |
179 | Ubiquitination | GLSLPPACTRAERRE CCCCCCCCCHHHHHH | 3.05 | 24816145 | |
180 | Phosphorylation | LSLPPACTRAERREV CCCCCCCCHHHHHHH | 34.71 | 20068231 | |
188 | Ubiquitination | RAERREVERVVVDAL HHHHHHHHHHHHHHH | 34.70 | 23503661 | |
196 | Phosphorylation | RVVVDALSGLKGDLA HHHHHHHHCCCHHHH | 43.74 | 24076635 | |
199 | Ubiquitination | VDALSGLKGDLAGRY HHHHHCCCHHHHHHE | 54.63 | 30230243 | |
199 | Acetylation | VDALSGLKGDLAGRY HHHHHCCCHHHHHHE | 54.63 | 26051181 | |
213 | Phosphorylation | YYRLSEMTEAEQQQL EEEHHHCCHHHHHHH | 28.17 | - | |
229 | Ubiquitination | DDHFLFDKPVSPLLT CCCCCCCCCCHHHHH | 39.73 | 23503661 | |
230 | Ubiquitination | DHFLFDKPVSPLLTA CCCCCCCCCHHHHHH | 33.39 | 30230243 | |
232 | Phosphorylation | FLFDKPVSPLLTAAG CCCCCCCHHHHHHHH | 20.54 | 28348404 | |
234 | Ubiquitination | FDKPVSPLLTAAGMA CCCCCHHHHHHHHHC | 5.31 | 24816145 | |
236 | Phosphorylation | KPVSPLLTAAGMARD CCCHHHHHHHHHCCC | 23.34 | 28102081 | |
251 | Phosphorylation | WPDARGIWHNNEKSF CCCCCCCEECCCCCE | 7.32 | 32142685 | |
260 | Ubiquitination | NNEKSFLIWVNEEDH CCCCCEEEEECCCCC | 3.48 | 23503661 | |
275 | Acetylation | TRVISMEKGGNMKRV EEEEEEECCCHHHHH | 64.57 | 26051181 | |
275 | Ubiquitination | TRVISMEKGGNMKRV EEEEEEECCCHHHHH | 64.57 | 24816145 | |
291 | Succinylation | ERFCRGLKEVERLIQ HHHHHHHHHHHHHHH | 63.64 | 23954790 | |
306 | Ubiquitination | ERGWEFMWNERLGYI HHCCHHHHCCCCEEE | 14.62 | 24816145 | |
312 | Phosphorylation | MWNERLGYILTCPSN HHCCCCEEEEECCCC | 9.43 | 28152594 | |
315 | Phosphorylation | ERLGYILTCPSNLGT CCCEEEEECCCCCCC | 16.89 | 27251275 | |
316 | Glutathionylation | RLGYILTCPSNLGTG CCEEEEECCCCCCCC | 2.89 | 22555962 | |
318 | Phosphorylation | GYILTCPSNLGTGLR EEEEECCCCCCCCCC | 47.00 | 27499020 | |
322 | Phosphorylation | TCPSNLGTGLRAGVH ECCCCCCCCCCCCEE | 35.89 | 27251275 | |
331 | Acetylation | LRAGVHIKLPLLSKD CCCCEEEECCCCCCC | 29.22 | 26051181 | |
336 | Phosphorylation | HIKLPLLSKDSRFPK EEECCCCCCCCCCHH | 41.94 | 21712546 | |
337 | Succinylation | IKLPLLSKDSRFPKI EECCCCCCCCCCHHH | 60.74 | 23954790 | |
337 | Acetylation | IKLPLLSKDSRFPKI EECCCCCCCCCCHHH | 60.74 | 26051181 | |
339 | Phosphorylation | LPLLSKDSRFPKILE CCCCCCCCCCHHHHH | 39.29 | 21712546 | |
343 | Acetylation | SKDSRFPKILENLRL CCCCCCHHHHHHHCC | 58.15 | 26051181 | |
349 | Methylation | PKILENLRLQKRGTG HHHHHHHCCHHCCCC | 46.80 | - | |
355 | Phosphorylation | LRLQKRGTGGVDTAA HCCHHCCCCCCCCCC | 34.49 | 23312004 | |
360 | Phosphorylation | RGTGGVDTAATGGVF CCCCCCCCCCCCCEE | 18.78 | 24076635 | |
363 | Phosphorylation | GGVDTAATGGVFDIS CCCCCCCCCCEEECC | 31.82 | 24076635 | |
396 | Glutathionylation | GVNYLIDCERRLERG CCHHHHCHHHHHHCC | 3.30 | 22555962 | |
407 | Methylation | LERGQDIRIPTPVIH HHCCCCCCCCCCCCC | 36.80 | - | |
410 | Phosphorylation | GQDIRIPTPVIHTKH CCCCCCCCCCCCCCC | 28.02 | 30266825 | |
415 | Phosphorylation | IPTPVIHTKH----- CCCCCCCCCC----- | 21.49 | 23312004 | |
441 | Phosphorylation | ------------------------------- ------------------------------- | 32142685 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KCRU_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KCRU_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ASB9_HUMAN | ASB9 | physical | 20302626 | |
HYEP_HUMAN | EPHX1 | physical | 26344197 | |
GPD1L_HUMAN | GPD1L | physical | 26344197 | |
CH10_HUMAN | HSPE1 | physical | 26344197 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00148 | Creatine |
loading...
Phosphorylation | |
Reference | PubMed |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-153, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-153, AND MASSSPECTROMETRY. |